Smith, Moore & Co’s iShares iBonds Dec 2023 Term Corporate ETF IBDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,146
Closed -$255K 403
2022
Q2
$255K Buy
10,146
+40
+0.4% +$1.01K 0.04% 322
2022
Q1
$255K Buy
10,106
+27
+0.3% +$687 0.03% 348
2021
Q4
$259K Buy
10,079
+80
+0.8% +$2.06K 0.04% 350
2021
Q3
$260K Buy
9,999
+43
+0.4% +$1.12K 0.04% 337
2021
Q2
$260K Sell
9,956
-1,558
-14% -$40.7K 0.04% 333
2021
Q1
$301K Buy
11,514
+38
+0.3% +$995 0.05% 292
2020
Q4
$301K Buy
11,476
+84
+0.7% +$2.2K 0.06% 259
2020
Q3
$299K Buy
11,392
+68
+0.6% +$1.78K 0.06% 252
2020
Q2
$297K Buy
11,324
+79
+0.7% +$2.04K 0.07% 245
2020
Q1
$281K Sell
11,245
-1,978
-15% -$50.2K 0.07% 227
2019
Q4
$338K Buy
13,223
+2,138
+19% +$54.6K 0.07% 236
2019
Q3
$284K Sell
11,085
-750
-6% -$19.1K 0.06% 254
2019
Q2
$301K Buy
11,835
+1,937
+20% +$48.5K 0.07% 259
2019
Q1
$248K Buy
+9,898
New +$243K 0.06% 272

Other funds holding IBDO

Smith, Moore & Co's IBDO Position: Q3 2022 in Review

Smith, Moore & Co sold out of iShares iBonds Dec 2023 Term Corporate ETF (IBDO) in Q3 2022, closing a stake of 10,146 shares — an estimated $255K sold.

Smith, Moore & Co first reported a position in IBDO in Q1 2019 and held it in 14 quarters. The position peaked at $338K in Q4 2019. 246 funds tracked by Wall St. Rank hold IBDO as of Q3 2022.

  • Smith, Moore & Co reported no remaining iShares iBonds Dec 2023 Term Corporate ETF position as of Q3 2022 after selling out during the quarter.
  • Smith, Moore & Co sold 10,146 iShares iBonds Dec 2023 Term Corporate ETF shares in Q3 2022, an estimated $255K.
  • Smith, Moore & Co first reported a position in iShares iBonds Dec 2023 Term Corporate ETF in Q1 2019 and held it in 14 quarters.
  • Smith, Moore & Co's iShares iBonds Dec 2023 Term Corporate ETF position peaked at $338K in Q4 2019.
  • 246 funds tracked by Wall St. Rank held iShares iBonds Dec 2023 Term Corporate ETF as of Q3 2022.

Based on Smith, Moore & Co's 13F filing for Q3 2022, filed 14 Nov 2022.